"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD

Breaking down biotech with Daphne Zohar: VC dynamics, drug development, and the Biosecure Act

Aug 7, 2024
Guest
Daphne Zohar
Daphne Zohar, Founder and CEO of Seaport Therapeutics, shares her deep insights into the biotech landscape. She discusses the complex challenges of drug development, particularly in psychiatric treatments, while shedding light on high failure rates and funding obstacles. Daphne explores the intersection of tech and biotech investment, emphasizing the regulatory hurdles and the implications of the Biosecure Act on innovation. She advocates for greater transparency in the industry and the necessity of political support to drive progress in patient care.
Ask episode
Chapters
Transcript
Episode notes
1
Intro
00:00 • 4min
2
Challenges in Psychiatric Drug Development
04:18 • 6min
3
Navigating Biotech and Tech Investment
10:28 • 20min
4
Political Leadership and Its Impact on Biotech Innovation
30:40 • 2min
5
Advocating for Transparency in the Biotech Industry
32:12 • 2min